A Clinical Trial to Evaluate the Effects of Adrenal Adapt on Sleep Quality, Daytime Energy, Stress Resilience, and Cognitive Performance.
Public ClinicalTrials.gov record NCT07893561. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a single-group, open-label, uncontrolled clinical trial designed to evaluate the effects of Adrenal Adapt, a commercially available dietary supplement, on sleep quality, daytime energy, stress resilience, and cognitive performance over a 12-week intervention period in 40 healthy adults aged 18-60.
Study identification
- NCT ID
- NCT07893561
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 40 participants
Conditions and interventions
Conditions
- Improves Daytime Energy Levels
- Reduces Afternoon Energy Crashes and Midday Fatigue
- Improves Overall Sleep Quality and Restorative Sleep
- Helps People Fall Asleep Faster and Wake Less During the Night
- Helps People Wake Feeling Refreshed
- Improves the Body's Resilience and Recovery in Response to Everyday Stress
- Reduces Perceived Stress and Feelings of Overwhelm
- Improves Cognitive Performance, Mental Clarity, and Calm Focus Throughout the Day
- Provides Calm, Steady Energy Without Jitteriness or Overstimulation
- Reduces Reliance on Caffeine for Daily Energy
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2026 (Actual)
- Primary completion
- Dec 2, 2026 (Estimated)
- Completion
- Dec 2, 2026 (Estimated)
- Last update posted
- Oct 26, 2026
2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Citruslabs | Las Vegas | Nevada | 89118 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07893561, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2026 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07893561 live on ClinicalTrials.gov.